Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

A single-blinded randomized placebo-controlled clinical trial of manipulation and mobilization in the treatment of Morton's neuroma
Govender N, Kretzmann H, Price JL, Brantingham JW, Globe G
Journal of the American Chiropractic Association 2007 Apr;44(3):8-18
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

INTRODUCTION: A review of the literature has revealed that, of the surgical and (especially) non-surgical randomized controlled trials studied for the treatment of Morton's neuroma, no sufficient evidence has been found to fully support the effectiveness of any intervention. Since surgery and steroid injections involve risks and complications, a need exists for investigation of the efficacy of alternative conservative therapy. A number of case reports in the literature indicate success using manual manipulation and mobilization procedures of the foot and ankle in the treatment of Morton's neuroma. This study aimed to analyze the efficacy of these procedures in the form of a randomized controlled trial. MATERIALS AND METHODS: This study of 40 subjects compares foot and ankle manipulation and mobilization with placebo (de-tuned ultrasound) in the management of Morton's neuroma. Outcome measures included the Numerical Pain Rating Scale (NRS) 101, a Short-form McGill Pain Questionnaire (SFMPQ), the Foot Function Index Pain (FFI-P) and the Foot Function Index Disability (FFI-D), Algometer pain pressure threshold, and pain pressure tolerance. RESULTS: Data were statistically analyzed for significance at a 95% confidence level with alpha (a) set at 0.05. The NRS-101 showed group B (manipulation and mobilization) to have a statistically significant improvement in perceived pain levels compared with group A (placebo) at 6 weeks (mean NRS 25.4 and 40.7 respectively, p = 0.03). Algometry pain pressure threshold and tolerance were also found to be statistically significantly improved in group B compared with group A (p = 0.02 and p = 0.02 respectively). Power was adequate for the NRS 101 primary outcome measure. No other statistically significant differences in subjective out-come measures (SFMPQ, FFI-P, and FFI-D) were found between the 2 groups. DISCUSSION: There is evidence that the addition of the manipulative treatment protocol was more efficacious in reducing subjects' perception of pain, but some limitations do exist. CONCLUSION: These findings suggest the possibility of short-term relief and efficacy for manipulation and mobilization in the treatment of Morton's neuroma.

Full text (sometimes free) may be available at these link(s):      help